The structural basis for the phospholipid remodeling by lysophosphatidylcholine acyltransferase 3

Qing Zhang, Deqiang Yao, Bing Rao, Liyan Jian, Yang Chen, Kexin Hu, Ying Xia, Shaobai Li, Yafeng Shen, An Qin, Jie Zhao, Lu Zhou, Ming Lei, Xian‐Cheng Jiang, Yu CaoNature Communications 2021 · DOI

TL;DR

This paper elucidates the molecular machinery behind lysophosphatidylcholine acyltransferase 3 (LPCAT3), a key enzyme in cell membrane remodeling. By combining X-ray crystallography and cryo-electron microscopy, the researchers reveal the enzyme's structure in various states, uncovering a unique "T-shaped" reaction chamber that explains its preference for polyunsaturated fatty acids and provides a basis for understanding phospholipid remodeling in health and disease.

What Problem Does This Paper Address?

Cell membranes are dynamic structures, and their composition, particularly the arrangement of fatty acids in phospholipids like phosphatidylcholine (PC), is crucial for membrane fluidity and protein function. This intricate balance is maintained through a process called phospholipid remodeling, where enzymes like lysophosphatidylcholine acyltransferases (LPCATs) play a vital role. Among the four known LPCATs, LPCAT3 is particularly important in metabolic tissues, preferentially incorporating polyunsaturated fatty acids into the sn-2 position of PC. However, the precise molecular mechanisms by which LPCAT3 achieves this substrate specificity and catalyzes the acyl transfer reaction remained largely unknown, hindering our understanding of its role in various physiological and pathological conditions, including metabolic disorders and atherosclerosis. This paper aims to fill this knowledge gap by providing high-resolution structural insights into LPCAT3.

Methods

The researchers employed a powerful combination of structural biology techniques:

  • X-ray Crystallography: This technique was used to determine the high-resolution structure of a truncated chicken LPCAT3 (cLPCAT3core) in its apo (unbound) state. This provided an initial detailed look at the enzyme's overall architecture.
  • Cryo-Electron Microscopy (cryo-EM): To understand how LPCAT3 interacts with its substrates, cryo-EM was crucial. They determined structures of cLPCAT3 in complex with its acyl donor (arachidonoyl-CoA, araCoA) and its acyl acceptor (lysophosphatidylcholine, LPC). This allowed them to visualize the enzyme in functional states.
  • Biochemical Assays (TLC): Thin-layer chromatography (TLC) assays were used to measure the enzymatic activity of wild-type LPCAT3 and various mutants. This helped to functionally validate the roles of specific residues and structural features identified in the structural studies.
  • Protein Engineering: Site-directed mutagenesis was used to create specific mutants of LPCAT3 to probe the function of key residues identified in the structural analysis.
  • Bioinformatics Tools: Programs like HOLLOW were used to analyze the internal cavities and tunnels within the protein structure.

Datasets

Not discussed in the paper.

Key Insights and Ideas

  • A Unique "T-Shaped" Reaction Chamber: LPCAT3 possesses a distinctive internal cavity shaped like a "T." This chamber is formed by transmembrane helices and is divided into a horizontal tunnel and a vertical tunnel. This architecture is key to accommodating both substrates and facilitating the reaction.
  • Substrate Specificity Explained: The horizontal tunnel appears to be designed for the acyl acceptor (LPC), while the vertical tunnel, with an adjacent "side pocket," is optimized for the bulky acyl donor (arachidonoyl-CoA). The side pocket's shape and hydrophobic lining are particularly suited for accommodating the long, unsaturated acyl chain of arachidonoyl-CoA, explaining LPCAT3's preference for polyunsaturated fatty acids.
  • Dual Catalytic Residues: The study identified two critical catalytic residues, N352 and H388, strategically positioned within the reaction chamber. N352 is proposed to activate the acyl donor, while H388 is implicated in activating the acyl acceptor.
  • Lateral Gate for Substrate Entry/Product Exit: A "lateral gate" formed by specific transmembrane helices (TM1 and TM6) is identified. This gate is crucial for the entry of LPC and the exit of the newly formed PC product, suggesting a dynamic mechanism for substrate exchange.
  • Non-Contact Dimerization: LPCAT3 forms a unique "non-contact" dimer, where protomers are held together by intermediary lipid molecules rather than direct protein-protein interactions. This unusual dimerization might influence its activity and localization.

Key Results

  • High-Resolution Structures: The paper presents the crystal structure of cLPCAT3core at 3.4 Å resolution and cryo-EM structures of dimeric cLPCAT3 bound to araCoA (3.49 Å) and LPC (3.57 Å).
  • Identification of Reaction Chamber: The structures clearly reveal the "T-shaped" reaction chamber, including the horizontal tunnel, vertical tunnel, and side pocket.
  • Substrate Binding Sites Mapped: The binding sites for both arachidonoyl-CoA and LPC within the respective tunnels and pockets were visualized and modeled.
  • Functional Validation of Catalytic Residues: Mutagenesis studies confirmed the essential roles of N352 and H388 in LPCAT3 activity. Mutations in these residues significantly impaired or abolished enzymatic function.
  • Substrate Preference Mechanism: The structural findings, supported by functional assays, provide a mechanistic explanation for LPCAT3's preference for polyunsaturated acyl donors, attributing it to the specific geometry and chemical environment of the side pocket.
  • Evidence for Dimerization: Cross-linking assays provided evidence for the existence of LPCAT3 dimers in membrane-bound states, despite the crystal structure showing a monomer.

Limitations and Future Work

  • Topology Uncertainty: While the study proposes an ER lumen-facing gate for acyl-CoA, the authors acknowledge the possibility of an opposite membrane topology, as seen in some other membrane-bound O-acyltransferases. Further experiments are suggested to definitively establish the topology.
  • Cytoplasmic Synthesis of Acyl-CoA: The paper notes that arachidonoyl-CoA is primarily synthesized in the cytoplasm, raising questions about its transport to the ER lumen for LPCAT3 activity. The mechanism of this transport remains to be elucidated.
  • Unmodeled Density: In the LPC-bound structure, an unmodeled electron density was observed in the side pocket, which the authors speculate might represent the PC product, but further studies are needed to confirm its identity and the mechanism of PC exit.
  • Biological Relevance of Dimerization: While evidence for dimerization is presented, its precise biological relevance and the role of the non-contact interface remain to be fully understood.
  • Inhibition Mechanisms: Understanding how LPCAT3 is regulated and how it can be targeted for therapeutic purposes (e.g., in metabolic disorders) is a crucial area for future research. The structural insights could guide the design of specific inhibitors.

Summary updated

Abstract

As the major component of cell membranes, phosphatidylcholine (PC) is synthesized de novo in the Kennedy pathway and then undergoes extensive deacylation-reacylation remodeling via Lands' cycle. The re-acylation is catalyzed by lysophosphatidylcholine acyltransferase (LPCAT) and among the four LPCAT members in human, the LPCAT3 preferentially introduces polyunsaturated acyl onto the sn-2 position of lysophosphatidylcholine, thereby modulating the membrane fluidity and membrane protein functions therein. Combining the x-ray crystallography and the cryo-electron microscopy, we determined the structures of LPCAT3 in apo-, acyl donor-bound, and acyl receptor-bound states. A reaction chamber was revealed in the LPCAT3 structure where the lysophosphatidylcholine and arachidonoyl-CoA were positioned in two tunnels connected near to the catalytic center. A side pocket was found expanding the tunnel for the arachidonoyl CoA and holding the main body of arachidonoyl. The structural and functional analysis provides the basis for the re-acylation of lysophosphatidylcholine and the substrate preference during the reactions.
BibTeX
@inproceedings{zhang2021structural,
  author = {Qing Zhang and Deqiang Yao and Bing Rao and Liyan Jian and Yang Chen and Kexin Hu and Ying Xia and Shaobai Li and Yafeng Shen and An Qin and Jie Zhao and Lu Zhou and Ming Lei and Xian‐Cheng Jiang and Yu Cao},
  title = {{The structural basis for the phospholipid remodeling by lysophosphatidylcholine acyltransferase 3}},
  booktitle = {Nature Communications},
  year = {2021},
  doi = {10.1038/s41467-021-27244-1},
}
Figure